What is Celcuity's SG&A?

Celcuity (CELC) reported SG&A of $17.44M in Q1 2026.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Celcuity CELC SG&A

SG&A at other companies

Eli LillyLLY

$2.93B+18.9%

Gilead SciencesGILD

$1.45B+15.3%

BridgeBio PharmaBBIO

$163.9M+54.1%

Medpace Holdings, Inc.MEDP

$47.92M-17.2%

Crinetics PharmaceuticalsCRNX

$47.83M+91.8%

TG TherapeuticsTGTX

$88.22M+75.3%

Other financials

Income statement

See full

Operating income-$50.5M-39.8%

Net income-$52.8M-42.8%

EPS (diluted)-$0.97-12.8%

Balance sheet

See full

Cash & equivalents$145.2M+781%

Total debt$137.9M+30.7%

Total equity$53.5M-38.2%

Total assets$410.2M+88.0%

Cash flow

See full

Operating cash flow-$55.1M-53.6%

CapEx$249.0K+315%

Free cash flow-$55.3M-54.0%

Valuation

See full

Market cap$4.28B+1,370%

Enterprise value$4.27B+1,086%

Returns & leverage

See full

Return on equity-275.2%-990pp

Debt / equity2.6×+1.4×

Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Celcuity's SG&A?: Celcuity (CELC) reported SG&A of $17.44M in Q1 2026.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.